Optogenetic control of a GEF of RhoA uncovers a signaling switch from retraction to protrusion
eLife · 2025
DOI: 10.7554/elife.93180 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Jean de Seze und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Physico Chimie Curie, Institut Curie, PSL Research University, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Optogenetics, Signal Transduction, rhoA GTP-Binding Protein, Rho Guanine Nucleotide Exchange Factors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Association pour la Recherche contre le Cancer.
Abstract (Originalsprache)
The ability of a single protein to trigger different functions is an assumed key feature of cell signaling, yet there are very few examples demonstrating it. Here, using an optogenetic tool to control membrane localization of RhoA nucleotide exchange factors (GEFs), we present a case where the same protein can trigger both protrusion and retraction when recruited to the plasma membrane, polarizing the cell in two opposite directions. We show that the basal concentration of the GEF prior to activation predicts the resulting phenotype. A low concentration leads to retraction, whereas a high concentration triggers protrusion. This unexpected protruding behavior arises from the simultaneous activation of Cdc42 by the GEF and sequestration of active RhoA by the GEF PH domain at high concentrations. We propose a minimal model that recapitulates the phenotypic switch, and we use its predictions to control the two phenotypes within selected cells by adjusting the frequency of light pulses. Our work exemplifies a unique case of control of antagonist phenotypes by a single protein that switches its function based on its concentration or dynamics of activity. It raises numerous open questions about the link between signaling protein and function, particularly in contexts where proteins are highly overexpressed, as often observed in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire Physico Chimie Curie, Institut Curie, PSL Research University, Sorbonne Université, Paris, France.
ORCID-Profile: Jean de Seze, Maud Bongaerts, Mathieu Coppey
Förderung
- Agence Nationale de la Recherche
- Association pour la Recherche contre le Cancer
Zitieren
APA
de Seze, J., Bongaerts, M., Boulevard, B., & Coppey, M. (2025). Optogenetic control of a GEF of RhoA uncovers a signaling switch from retraction to protrusion. eLife. https://doi.org/10.7554/elife.93180
Vancouver
de Seze J, Bongaerts M, Boulevard B, Coppey M. Optogenetic control of a GEF of RhoA uncovers a signaling switch from retraction to protrusion. eLife. 2025. doi:10.7554/elife.93180
BibTeX
@article{deSeze2025,
author = {de Seze, Jean and Bongaerts, Maud and Boulevard, Benoit and Coppey, Mathieu},
title = {Optogenetic control of a GEF of RhoA uncovers a signaling switch from retraction to protrusion},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.93180}
}
EUVIMED